---
$id: https://graph.org.ai/products/commodity/51384607
$type: Product
source: UNSPSC
code: "51384607"
title: "Celecoxib"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Celecoxib

**UNSPSC Code**: 51384607
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H14F3N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JCX84Q7J1L, chemically known as benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)- but generally known as celecoxib, which bears US NIH Compound Identifier 2662. European Medicines Agency schedules Celecoxib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01143MIG. The term CELECOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules celecoxib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule celecoxib under HS 29350090 and SITC 51580. As of Q4 2014, CELECOXIB remains the US FDA Preferred Term for this commodity. Celecoxib bears US NLM identifiers UMLS ID C0538927 and NCI Concept Code C1728. SMILES: S(=O)(=O)(N)C1CCC(N2NC(CC2C2CCC(CC2)C)C(F)(F)F)CC1.

